Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases
Daniela Massi(University of Florence), Angelo Paolo Dei Tos(Ca' Foncello Hospital), Thomas Mentzel(Dermatopathologie Friedrichshafen), John Panelos(University of Ioannina), Alessandro Franchi(University of Florence), Marco Santucci(Okayama University), Aikaterini Zioga(University of Ioannina), Michal Michal(Charles University), Gabrina Tragni(Tumori Foundation), José Luis Rodríguez‐Peralto(Universidad Complutense de Madrid), Gerardo Ferrara(Azienda Ospedaliera G.Rummo), Silvana Di Palma(Royal Surrey County Hospital), Martin Cook(Royal Surrey County Hospital), Dmitry V. Kazakov(Charles University), Ana B. Enguita(Spanish Society of Hematology and Hemotherapy), Llúcia Alós(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 120
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k